Filing Flows › Comparisons › XERS vs CRMD
Xeris Biopharma Holdings vs CorMedix: XERS and CRMD compared
Xeris Biopharma Holdings is the larger company: $107M of revenue in its latest quarter (Q3 2026) against $102M for CorMedix (Q2 2026). CorMedix is growing faster (+156% against +44% a year earlier). CorMedix is more profitable, with an operating margin of 42.1% against 15.8%.
Where the money goes: XERS and CRMD
Xeris Biopharma Holdings (XERS) · Q3 2026
Xeris Biopharma Holdings, Q3 2026: revenue $107M (+44% year over year), operating margin 15.8%, net earnings $11.3M, operating cash flow $35.5M. The chart follows the revenue to costs, profit and cash.
CorMedix (CRMD) · Q2 2026
CorMedix, Q2 2026: revenue $102M (+156% year over year), operating margin 42.1%, net earnings $26.0M, operating cash flow $86.2M. The chart follows the revenue to costs, profit and cash.
| Xeris Biopharma Holdings (XERS) | CorMedix (CRMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $107M | $102M |
| Revenue growth, Y/Y | +44% | +156% |
| Gross margin | — | 75.7% |
| Operating margin | 15.8% | 42.1% |
| Net earnings | $11.3M | $26.0M |
| Net margin | 10.5% | 25.5% |
| Operating cash flow | $35.5M | $86.2M |
| Free cash flow | — | $85.7M |
Where the revenue comes from
Xeris Biopharma Holdings
- Product revenue, net: $106M (99%)
- Royalty, contract and other revenue: $958K (1%)
CorMedix
- Product sales, net: $94.3M (93%)
- Contract revenue: $5.0M (5%)
- Grant income: $2.6M (3%)
Questions
Which is bigger, Xeris Biopharma Holdings or CorMedix?
Xeris Biopharma Holdings is the larger company: $107M of revenue in its latest quarter (Q3 2026) against $102M for CorMedix (Q2 2026).
Is Xeris Biopharma Holdings or CorMedix growing faster?
CorMedix is growing faster (+156% against +44% a year earlier).
Which is more profitable, Xeris Biopharma Holdings or CorMedix?
CorMedix is more profitable, with an operating margin of 42.1% against 15.8%.
More: Xeris Biopharma Holdings earnings · how Xeris Biopharma Holdings makes money · CorMedix earnings · how CorMedix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.